'Molecular Glue' Turns a Cancer Driver Into a Built-in Kill Switch in Stanford Medicine Study
August 21, 2026
August 21, 2026
STANFORD, California, Aug. 21 (TNSjou) -- Stanford University School of Medicine issued the following news:
* * *
'Molecular glue' turns a cancer driver into a built-in kill switch in Stanford Medicine study
A lymphoma driver called BCL6 suppresses the expression of cell death genes. A new molecule designed at Stanford Medicine blocks its activity and activates downstream genes to trigger cell death.
By Krista Conger
A tw . . .
* * *
'Molecular glue' turns a cancer driver into a built-in kill switch in Stanford Medicine study
A lymphoma driver called BCL6 suppresses the expression of cell death genes. A new molecule designed at Stanford Medicine blocks its activity and activates downstream genes to trigger cell death.
By Krista Conger
A tw . . .